Massachusetts Rx
Executive Summary
Massachusetts may suspend its Rx drug insurance program Prescription Advantage April 1 if its waiver request is not approved by the Centers for Medicare & Medicaid Services. The waiver would reimburse the state for half the costs of the $100 mil.-a-year drug program; 80,000 seniors are enrolled (1"The Pink Sheet" April 9, 2001, p. 17). Massachusetts plans to develop a new senior drug discount program by the end of March...
You may also be interested in...
Massachusetts To Assume Risk In Rx Insurance Contract With AdvancePCS
Massachusetts will serve as the risk-bearing entity in its contract with the pharmacy benefit manager AdvancePCS for the state's prescription drug insurance program.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip